Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MMTEC Inc MTC

Mmtec Inc is a China-based company primarily engaged in asset management services based on platforms. The Company is principally engaged in providing complete suite trading solutions, including fund creation, distribution, custody, trading and settlement services, to help these financial institutions accelerate their integration into overseas markets. The Company's systems include ETN counter... see more

Recent & Breaking News (NDAQ:MTC)

Ichnos Sciences Presents Preclinical Data Confirming Potential For ISB 1342 In Relapsed/Refractory Multiple Myeloma At 2021 ASCO Annual Meeting

PR Newswire June 4, 2021

Natera Announces New Prospera(TM) Data at the ATC 2021 Virtual Connect Conference

PR Newswire June 4, 2021

DCISionRT by PreludeDx Identifies Women with DCIS with Unacceptably High Rates of Local Recurrence after Breast Conserving Surgery and Radiation Therapy

PR Newswire June 4, 2021

Lilly Announces New Clinical Data from Verzenio and Oral SERD Programs at the American Society of Clinical Oncology Annual Meeting

PR Newswire June 4, 2021

AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591

PR Newswire June 4, 2021

Phase 2 Fight Trial Continues To Show Improved Overall Survival With Bemarituzumab Plus Chemotherapy In Patients With FGFR2b+ Gastric And Gastroesophageal Cancers

PR Newswire June 4, 2021

Auransa and POLARISqb enter research collaboration finding treatments for neglected women's diseases

PR Newswire June 4, 2021

Results from IMBRUVICA® (ibrutinib) RESONATE-2 Study Provide Up to Seven Years of Progression-Free and Overall Survival Data in First-Line Chronic Lymphocytic Leukemia (CLL)

PR Newswire June 4, 2021

ScienceMedia Strengthens Clinical Team with Clinical Research Coordinator, Monica Bandy

PR Newswire June 4, 2021

Steep Decline in Prostate Cancer Outpatient Visits During the COVID-19 Pandemic, According to Research by Verana Health and American Urological Association

PR Newswire June 4, 2021

New 100-Day Course Starting June 5 Shares Ancient Secrets of Master Healer Dr. Pankaj Naram

PR Newswire June 4, 2021

Heart-Valve-Surgery.com Launches "Clinical Trials Education Platform" to Educate & Empower Heart Valve Patients

PR Newswire June 4, 2021

US Navy Veterans Mesothelioma Advocate Appeals to the Family of a Navy Veteran with Mesothelioma to Not Hire a Local Car Accident Attorney -- Before Talking First to Attorney Erik Karst of Karst von Oiste -- Get a Much Better Compensation Result

PR Newswire June 4, 2021

Guardian Research Network Celebrates Debut of New Early Cancer Detection Test

PR Newswire June 4, 2021

DarioHealth Releases Study Demonstrating the Impact of Personalized Digital Interventions to Improve Self-Management of Diabetes

PR Newswire June 4, 2021

Peijia Medical and CR PHARMA COMM Sign Memorandum of Strategic Cooperation

PR Newswire June 4, 2021

Neighbourly Announces Closing of Over-Allotment Option in connection with Initial Public Offering

Canada NewsWire June 4, 2021

Advaccine Announces First Participants Dosed in Phase 2 Study of ADV110 Evaluating Respiratory Syncytial Virus (RSV) Vaccine Candidate in Australia

PR Newswire June 4, 2021

Phio Pharmaceuticals Presents New In Vivo Data at the 2021 ASCO Annual Meeting Showing Dual-Targeting INTASYL Offers Increased Efficacy and Safety Potential Over Other Therapeutic Approaches

PR Newswire June 4, 2021

MEI Pharma to Host Investor and Analyst Video Webcast Event Following 2021 ASCO Annual Meeting

PR Newswire June 4, 2021